Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70010-184

7 FDA label images from Granules Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70010-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine-struc (Venlafaxine Struc)

Venlafaxine-struc (Venlafaxine Struc)
Chemical structure of venlafaxine hydrochloride showing the molecular arrangement including a cyclohexane ring, an aromatic ring with a methoxy group, and the hydrochloride ion (HCl). The image includes labeled nitrogen, hydroxyl, and dimethylamino groups.*
FDA Label Image

Venlafaxine-fig1 (Venlafaxine Fig1)

Venlafaxine-fig1 (Venlafaxine Fig1)
A dot plot chart showing fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax, AUC, ODV) of venlafaxine in special populations including hepatic impairment, renal impairment, CYP2D6 metabolizer status, age (≥60 years), and gender (females/males). The x-axis represents change relative to the reference value from 0 to 3.5, highlighting variation in venlafaxine exposure across these groups.*
FDA Label Image

Venlafaxine-fig2 (Venlafaxine Fig2)

Venlafaxine-fig2 (Venlafaxine Fig2)
A plot showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC) of venlafaxine and its metabolite ODV when co-administered with various interacting drugs such as ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value, and the y-axis lists interacting drugs and analytes.*
FDA Label Image

Venlafaxine-fig3 (Venlafaxine Fig3)

Venlafaxine-fig3 (Venlafaxine Fig3)
A scatter plot chart showing fold change and 90% confidence intervals for various pharmacokinetic parameters (Cmax and AUC) of different analytes when interacted with specific drugs. The x-axis represents the change relative to a reference value, ranging from 0 to 3, while the y-axis lists interacting drugs alongside analytes and pharmacokinetic variables.*
FDA Label Image

Venlafaxine-37.5mg-30s (Venlafaxine 37.5mg 30s)

Venlafaxine-37.5mg-30s (Venlafaxine 37.5mg 30s)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5 mg, in a 30-capsule package. Manufactured by Granules India Limited, Hyderabad, India, and labeled for Granules Pharmaceuticals Inc., Chantilly, VA. Includes NDC 70010-184-03, storage instructions at 20° to 25°C, barcode, and a note to dispense the Medication Guide with each prescription.*
FDA Label Image

Venlafaxine-75mg-30s (Venlafaxine 75mg 30s)

Venlafaxine-75mg-30s (Venlafaxine 75mg 30s)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, available in a bottle of 30 capsules. The label states the active ingredient and dosage strength, mentions dispensing the Medication Guide to patients, and provides storage instructions. Manufactured by Granules India Limited and labeled for Granules Pharmaceuticals Inc. The label includes a barcode and notes the product is made in India.*
FDA Label Image

Venlafaxine-150mg-30s (Venlafaxine 150mg 30s)

Venlafaxine-150mg-30s (Venlafaxine 150mg 30s)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg. The label states a package count of 30 capsules and indicates dispensing the Medication Guide to patients. Manufactured by Granules India Limited, Hyderabad, India, and labeled for Granules Pharmaceuticals Inc., Chantilly, VA. Includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.